Skip to content

Mindfulness-based supportive therapy on reducing suffering in patients with advanced cancer: randomised controlled trial

S. Tan, Chung-Huey Chee, Chin-Fei Ngai, S. L. Hii, Yi Tan, Chong-Guan Ng, D. Capelle, Sheriza Izwa Zainuddin, E. Loh, C. Lam, C. Chai, D. Ng

BMJ Supportive & Palliative Care April 22, 2022 DOI: 10.1136/bmjspcare-2021-003349 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 73
Population Patients with advanced cancer and an overall suffering score of 4/10 or higher on the Suffering Pictogram at the University of Malaya Medical Centre, Malaysia
Intervention Mindfulness-based supportive therapy (MBST)
Measures Suffering Pictogram, Hospital Anxiety and Depression Scale, Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being
Topics Meditation
Key findings Mindfulness-based supportive therapy reduced overall suffering and improved anxiety, depression, and spiritual well-being more than the control condition in patients with advanced cancer. Median changes favored MBST on suffering (-2.0 vs -1.0), Hospital Anxiety and Depression Scale total (-4.0 vs -3.0), and Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being total (+14.5 vs +5.0).

Abstract

Objectives: Suffering is common among patients with advanced cancer. The practice of mindfulness during patient care can potentially reduce suffering. We aimed to examine the efficacy of mindfulness-based supportive therapy (MBST) on reducing suffering in patients with advanced cancer.

Methods: We conducted a parallel-group, single-blinded, randomised controlled trial at the University of Malaya Medical Centre, Malaysia. Seventy-three patients with advanced cancer with an overall suffering score ≥4/10 based on the Suffering Pictogram were recruited and randomly assigned into either the MBST group (n=34) or the control group (n=39).

Results: There was a statistically significant reduction in the overall suffering score in the MBST group compared with the control group (U=432.5, median1=−2.0, median2=−1.0, z=−2.645, p=0.008). There was also significant improvement in the total Hospital Anxiety and Depression Scale score (U=483.5, median1=−4.0, median2=−3.0, z=−1.994, p=0.046), and the total Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being score (U=252.0, median1=+14.5, median2=+5.0, z=−4.549, p=0.000) in the MBST group compared with the control group.

Conclusions: The results provided evidence that the practice of MBST during patient care could promote positive psychosocial outcomes.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Cited by 5

Cites 6

and 1 more in the library

Explore topics